Omega-3 fatty acids may inhibit prostate cancer cell growth
the ONA take:
In contradiction to a 2013 study, researchers have found a mechanism in omega-3 fatty acids may inhibit the growth and spread of prostate cancer cells. The new study was published in the Journal of Pharmacology and Experimental Therapeutics.
Kathryn Meier, PhD, and two students at Washington State University looked at prostate cell cultures and found that fatty acids are able to bind to FFA4, the “free fatty acid receptor 4”, which inhibits growth factors and suppresses the spread of cancer cells.
“This kind of knowledge could lead us to better treat or prevent cancer because now we know how it works,” Dr. Meier said.
This study contrasts with a 2013 study published in the Journal of the National Cancer Institute which found that men with higher levels of omega-3 fatty acids in their blood had a greater risk of developing prostate cancer.
However, it is still unclear if the effect can be obtained through dietary supplements, and that the drug needs to be in a cancer cell constantly in order to take effect.
A mechanism in omega-3 fatty acids may inhibit the growth and spread of prostate cancer cells.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|